1 Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) (KGG, DS); Department of Pathology (RM) and Marie-Josée and Henry R. Kravis Center for Molecular Oncology (RM), Memorial Sloan Kettering Cancer Center, New York, NY; Integriertes Forschungs- und Behandlungszentrum (IFB) Sepsis und Sepsisfolgen, Center for Sepsis Control and Care (CSCC) University Hospital Jena, Jena Germany (AS). klaus.griewank@uk-essen.de dirk.schadendorf@uk-essen.de.
2 Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium (DKTK) (KGG, DS); Department of Pathology (RM) and Marie-Josée and Henry R. Kravis Center for Molecular Oncology (RM), Memorial Sloan Kettering Cancer Center, New York, NY; Integriertes Forschungs- und Behandlungszentrum (IFB) Sepsis und Sepsisfolgen, Center for Sepsis Control and Care (CSCC) University Hospital Jena, Jena Germany (AS).